Profiel
Kelsey Tsai is a Vice President for Sandbox Healthcare.
She supports the Blue Venture Fund’s investments in Thrive (now Exact Sciences), Onc.AI, Sempre Health, AbleTo and Workit Health.
Prior to Sandbox, Kelsey was an MBA associate at ARCH Venture Partners, as well as an Innovation Fund associate for the University of Chicago’s seed stage tech and life sciences fund.
Kelsey started her career as a biotech equity research analyst at Morningstar.
Kelsey holds an MBA from the University of Chicago Booth School of Business and a BA in Economics from Georgetown University.
She is also a CFA charterholder.
Actieve functies van Kelsey Tsai
| Bedrijven | Functie | Begin |
|---|---|---|
213 Management LLC
 213 Management LLC Investment ManagersFinance 213 Management LLC (213 Management) is a venture capital firm founded in 2003 by Bob Shapiro and Nick Rosa. The firm is headquartered in Chicago, Illinois. | Private Equity Investor | 01-10-2021 |
Opleiding van Kelsey Tsai
| The University of Chicago Booth School of Business | Masters Business Admin |
| Georgetown University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
213 Management LLC
213 Management LLC Investment ManagersFinance 213 Management LLC (213 Management) is a venture capital firm founded in 2003 by Bob Shapiro and Nick Rosa. The firm is headquartered in Chicago, Illinois. | Finance |